Abstract
Basic neuroscience is a rapidly moving field, and the nervous system is a vast frontier only a small fraction of which has been explored. The potential for discovery of new molecules and concepts in basic neuroscience to be directly applied to the treatment of human neurological disease is high. However, this potential is not fulfilled as often as possible for a multitude of reasons, some of which were dramatized in the recent popular movie “Extraordinary Measures” in which a new enzyme replacement therapy for Pompe’s disease, a glycogen storage disease with dramatic CNS complications, went through a number of hurdles from bench to bedside.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1999;53(3):457–65.
Coles AJ, Compston DA, Selmaj KW, et al. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med. 2008;359(17):1786–801.
O’Connor KC, Appel H, Bregoli L, et al. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol. 2005;175(3):1974–82.
Owens GP, Bennett JL, Lassmann H, et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol. 2009;65(6):639–49.
Diener HC, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke. 2008;39(6):1751–8.
Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244–50.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pachner, A.R. (2012). Neuroimmunological Molecules and Translational Medicine. In: A Primer of Neuroimmunological Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-2188-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2188-7_17
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-2187-0
Online ISBN: 978-1-4614-2188-7
eBook Packages: MedicineMedicine (R0)